TNFRSF4 and acute myeloid leukemia: This association between the expression of OX40 at the molecular level and unfavorable disease outcome appears to corroborate the observation of Gu et al.16, who likewise reported a poorer outcome for AML patients with documented RNA expression of the OX40 gene in a retrospective TCGA analysis16.